Mouse Model Preparation Using HSV-1 and Hydrocortisone

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for developing animal models of herpes simplex virus infection do not effectively produce clear herpes lesions around the lips, limiting their usefulness for vaccine development and therapeutic agent testing.

Innovation Solution

A method involving the use of herpes simplex virus type 1 (HSV-1) and hydrocortisone to prepare a mouse model of herpes, where the skin is damaged, inoculated with HSV-1, and then treated with hydrocortisone to induce clear herpes lesions around the lips.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional methods are used to prepare animal models of herpes simplex virus infection, then the model can be established, but clear herpes lesions around the lips do not appear

Engineering Contradiction:
Improveclarity of herpes lesionsVSAvoidusefulness for vaccine development
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

Hydrocortisone is introduced as an intermediary substance to facilitate the appearance of clear herpes lesions. The steroid hormone mediates between the HSV-1 infection and the desired clinical manifestation, enabling the model to display characteristic lip lesions that were previously absent in conventional models

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The immune status parameter of the animal model is changed through hydrocortisone administration. This parameter modification creates conditions favorable for herpes lesion development, transforming the model from one that fails to show lesions to one that clearly displays them around the lips

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If the immune status is lowered to promote herpes lesion development, then lesions appear more clearly, but the animal's health and welfare may be compromised

Engineering Contradiction:
Improveclarity of herpes lesionsVSAvoidimpact on animal health
Core Design Contradiction:
Manufacturing precisionVSObject-affected harmful factors

Solution Approach 1:

Instead of completely suppressing the immune system, partial immunosuppression is achieved through hydrocortisone administration. This partial action is sufficient to promote herpes lesion development while avoiding the severe health consequences of complete immune suppression, maintaining animal welfare

Inventive Principle:
Principle #16Partial or excessive action

3Ease of manufacture

If no adjuvant is used in the inoculation process, then the procedure is simpler, but herpes lesions do not develop clearly

Engineering Contradiction:
Improvesimplicity of inoculation procedureVSAvoidclarity of herpes lesions
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

Hydrocortisone serves as a chemical intermediary that bridges the gap between simple inoculation and clear lesion development. Rather than complicating the inoculation procedure with multiple steps or substances, a single hydrocortisone injection facilitates the entire lesion formation process

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method successfully creates a mouse model with clearly visible herpes lesions, enhancing its utility for developing therapeutic agents against herpes simplex virus infection by providing a more accurate representation of the disease.

Implementation Method 1

injecting the reared mouse with hydrocortisone

Methodology Applied
Scientific EffectImmunosuppression:

Data Source

PatentUS12329137B2Method of preparing mouse model of herpes
Publication Date: 2025.06.17 AJOU UNIV IND ACADEMIC COOP FOUND
  • US12329137B2 patent drawing
  • US12329137B2 patent drawing
  • US12329137B2 patent drawing

AI summary

A method of preparing a mouse model of herpes using a herpes simplex virus and hydrocortisone, and a mouse model of herpes prepared using the method are disclosed. The method makes it possible to obtain an animal model in which symptoms of herpes clearly appear. The obtained animal model can be widely used in the development of therapeutic agents for herpes simplex virus infection. A use of the mouse model in screening and developing a candidate therapeutic agent is also disclosed.